Interferon alpha - sustained release
Alternative Names: Sustained release interferon alphaLatest Information Update: 12 Nov 2021
At a glance
- Originator biopartners GmbH; DURECT Corporation; Minster Pharmaceuticals
- Developer DURECT Corporation; Minster Pharmaceuticals
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 07 Jun 2005 Discontinued - Preclinical for Hepatitis C treatment in Switzerland (Injection)
- 07 Jun 2005 Discontinued - Preclinical for Hepatitis C treatment in USA (Injection)
- 24 Jan 2003 Preclinical trials in Hepatitis C treatment in Switzerland (Injection)